Loading...

VENDAJE AC National Launch And BioRetain Data To Drive Future Market Expansion

Published
10 Mar 25
Updated
09 Apr 25
AnalystConsensusTarget's Fair Value
US$49.56
85.3% undervalued intrinsic discount
09 Apr
US$7.30
Loading
1Y
-35.4%
7D
22.5%

Author's Valuation

US$49.6

85.3% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 9.84%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 43%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.